Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METYRAPONE Cause Disseminated intravascular coagulation? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Disseminated intravascular coagulation have been filed in association with METYRAPONE (Metopirone). This represents 1.1% of all adverse event reports for METYRAPONE.

6
Reports of Disseminated intravascular coagulation with METYRAPONE
1.1%
of all METYRAPONE reports
3
Deaths
4
Hospitalizations

How Dangerous Is Disseminated intravascular coagulation From METYRAPONE?

Of the 6 reports, 3 (50.0%) resulted in death, 4 (66.7%) required hospitalization, and 3 (50.0%) were considered life-threatening.

Is Disseminated intravascular coagulation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METYRAPONE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does METYRAPONE Cause?

Off label use (277) Nausea (53) Drug ineffective (39) Pneumocystis jirovecii pneumonia (31) Fatigue (30) Vomiting (27) Dizziness (26) Adrenal insufficiency (23) Anaemia (23) Exposure during pregnancy (22)

What Other Drugs Cause Disseminated intravascular coagulation?

PREDNISOLONE (362) METHOTREXATE (347) DEXAMETHASONE (323) METHYLPREDNISOLONE (307) NIVOLUMAB (305) CYCLOPHOSPHAMIDE (286) TACROLIMUS (278) PREDNISONE (277) VINCRISTINE (245) OXALIPLATIN (231)

Which METYRAPONE Alternatives Have Lower Disseminated intravascular coagulation Risk?

METYRAPONE vs MEXILETINE METYRAPONE vs MIANSERIN METYRAPONE vs MICAFUNGIN METYRAPONE vs MICARDIS METYRAPONE vs MICONAZOLE

Related Pages

METYRAPONE Full Profile All Disseminated intravascular coagulation Reports All Drugs Causing Disseminated intravascular coagulation METYRAPONE Demographics